[Targeted immunotherapy against interleukin 2 receptors (IL-2R)--an attempt at synthesis]. 1992

T Sabliński, and M A Wasik, and N L Tilney, and J W Kupiec-Wegliński
Surgical Research Laboratory, Harvard Medical School, Boston, Massachusetts.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D015375 Receptors, Interleukin-2 Receptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN. IL-2 Receptors,Interleukin-2 Receptor,Interleukin-2 Receptors,Receptors, IL-2,Receptors, T-Cell Growth Factor,T-Cell Growth Factor Receptors,IL-2 Receptor,IL2 Receptor,IL2 Receptors,Interleukin 2 Receptor,Receptor, TCGF,T-Cell Growth Factor Receptor,TCGF Receptor,TCGF Receptors,IL 2 Receptor,IL 2 Receptors,Interleukin 2 Receptors,Receptor, IL-2,Receptor, IL2,Receptor, Interleukin 2,Receptor, Interleukin-2,Receptors, IL 2,Receptors, IL2,Receptors, Interleukin 2,Receptors, T Cell Growth Factor,Receptors, TCGF,T Cell Growth Factor Receptor,T Cell Growth Factor Receptors

Related Publications

T Sabliński, and M A Wasik, and N L Tilney, and J W Kupiec-Wegliński
September 1992, Pharmacological research,
T Sabliński, and M A Wasik, and N L Tilney, and J W Kupiec-Wegliński
February 1987, Transplantation proceedings,
T Sabliński, and M A Wasik, and N L Tilney, and J W Kupiec-Wegliński
July 1990, Medical laboratory sciences,
T Sabliński, and M A Wasik, and N L Tilney, and J W Kupiec-Wegliński
January 2004, Current topics in microbiology and immunology,
T Sabliński, and M A Wasik, and N L Tilney, and J W Kupiec-Wegliński
February 1989, Transplantation proceedings,
T Sabliński, and M A Wasik, and N L Tilney, and J W Kupiec-Wegliński
January 1990, The Journal of nuclear medicine and allied sciences,
T Sabliński, and M A Wasik, and N L Tilney, and J W Kupiec-Wegliński
October 2002, International journal of clinical oncology,
Copied contents to your clipboard!